Table 1.

Summary of results of bone marrow transplantation experiments


Adoptive transfer protocol

No. of mice receiving transplants

No. of mice with leukemia

Survival time, d

Terminal WBC count, × 109/L

Spleen total yield, × 107 ± SD

Leukemia onset, wk
BALB/c wt       
ICN1   16   16   58   158.5   88.0 ± 8.3   2  
Empty, killed   11   0   58   10.2   4.5 ± 0.7   NA  
Rag2−/−       
ICN1   13   12   80   27.6   23.2 ± 2.6   8  
ICN1 + 1 × CD3   15   15   77   28.1   35.7 ± 4.3   3  
ICN1 + 3 × CD3   13   13   62   180.2   91.8 ± 11.2   3  
Empty + 3 × CD3, killed
 
12
 
0
 
76
 
9.9
 
1.7 ± 0.2
 
NA
 

Adoptive transfer protocol

No. of mice receiving transplants

No. of mice with leukemia

Survival time, d

Terminal WBC count, × 109/L

Spleen total yield, × 107 ± SD

Leukemia onset, wk
BALB/c wt       
ICN1   16   16   58   158.5   88.0 ± 8.3   2  
Empty, killed   11   0   58   10.2   4.5 ± 0.7   NA  
Rag2−/−       
ICN1   13   12   80   27.6   23.2 ± 2.6   8  
ICN1 + 1 × CD3   15   15   77   28.1   35.7 ± 4.3   3  
ICN1 + 3 × CD3   13   13   62   180.2   91.8 ± 11.2   3  
Empty + 3 × CD3, killed
 
12
 
0
 
76
 
9.9
 
1.7 ± 0.2
 
NA
 

Retroviruses (ICN1 or empty) and number of anti-CD3 injections (1 ×, single; 3 ×, triple) used in the transplantation assay are indicated. Leukemia onset is defined as time (in weeks) after bone marrow transplantation when EGFP+CD4+CD8+ cells were identified in the peripheral blood.

NA indicates not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal